- Clinical Trials
- April 2024
- 40 Pages
Global
From €1214EUR$1,250USD£1,047GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1457EUR$1,500USD£1,257GBP
- Report
- June 2023
- 200 Pages
Global
From €7284EUR$7,500USD£6,284GBP
- Report
- November 2023
- 190 Pages
Global
From €4759EUR$4,900USD£4,106GBP
- Report
- October 2023
- 172 Pages
Global
From €4759EUR$4,900USD£4,106GBP
- Report
- October 2023
- 190 Pages
Global
From €4759EUR$4,900USD£4,106GBP
- Report
- October 2023
- 190 Pages
Global
From €4759EUR$4,900USD£4,106GBP
- Report
- December 2023
- 180 Pages
Global
From €4657EUR$4,795USD£4,018GBP
- Report
- December 2023
- 100 Pages
Africa
From €3686EUR$3,795USD£3,180GBP
- Report
- December 2023
- 80 Pages
United States
From €2520EUR$2,595USD£2,174GBP
- Report
- November 2021
- 295 Pages
Global
From €2671EUR$2,750USD£2,304GBP
€5342EUR$5,500USD£4,608GBP
- Report
- January 2021
Global
From €3093EUR$3,185USD£2,669GBP
€4419EUR$4,550USD£3,812GBP
- Report
- August 2022
- 109 Pages
Global
From €4614EUR$4,750USD£3,980GBP
- Report
- June 2020
- 113 Pages
Global
From €4614EUR$4,750USD£3,980GBP
- Report
- August 2022
- 118 Pages
Global
From €4371EUR$4,500USD£3,770GBP
- Drug Pipelines
- October 2020
- 90 Pages
Global
From €1943EUR$2,000USD£1,676GBP
- Drug Pipelines
- July 2020
- 80 Pages
Global
From €1943EUR$2,000USD£1,676GBP
- Drug Pipelines
- June 2020
- 76 Pages
Global
From €1943EUR$2,000USD£1,676GBP
- Drug Pipelines
- August 2019
- 47 Pages
Global
From €1943EUR$2,000USD£1,676GBP
- Report
- December 2023
- 80 Pages
Argentina
From €2520EUR$2,595USD£2,174GBP
Amphotericin B is an antifungal drug used to treat a variety of fungal infections, including those caused by Candida, Aspergillus, and Cryptococcus species. It is commonly used to treat systemic fungal infections, such as those affecting the lungs, heart, and central nervous system. It is also used to treat fungal infections of the skin, nails, and eyes. Amphotericin B is a polyene macrolide antibiotic, and is the most commonly used antifungal drug in the world. It is available in both intravenous and oral formulations, and is often used in combination with other antifungal drugs.
The Amphotericin B market is a subset of the larger Infectious Diseases Drugs market. It is a highly competitive market, with a number of companies offering Amphotericin B products. Some of the major players in the market include Pfizer, Merck, Novartis, Sanofi, and AstraZeneca. Show Less Read more